University of California San Francisco

Peter A. Schneider
Peter
Schneider
MD

Professor of Surgery
Division of Vascular & Endovascular Surgery

Academic Office:
400 Parnassus Ave, A581, Box 0222
San Francisco, CA 94143
Tel: 415-353-4366
Email: [email protected] 
Asst: [email protected]

Vascular Surgery Clinic at SFVA:
4150 Clement Street, 
San Francisco, CA 94121
Tel: 415-221-4810 x25496 

Biography

Dr. Peter A. Schneider is a vascular surgeon with expertise in treating a broad range of conditions involving the blood vessels, including carotid artery disease, diabetic vascular disease and thoracic aortic aneurysm.

Schneider's participation in vascular disease research over the past 25 years has included designing trials to evaluate new treatments, providing oversight, analyzing data, presenting findings and publishing results. He has served as principal investigator for numerous national clinical trials. He has consulted on trials to show efficacy and gain regulatory approval for many vascular devices, met with the Food and Drug Administration (FDA) and testified at FDA panel hearings. His experience also includes performing procedures for several first-in-human trials.

Schneider earned his medical degree from the Johns Hopkins School of Medicine and completed a residency in general surgery and a fellowship in vascular surgery at UCSF. Before joining the UCSF faculty, he was the founding member and chief of Kaiser Permanente Hawaii's vascular surgery division. At Kaiser, he developed an aneurysm screening and monitoring program and a registry for patients with carotid artery disease. He oversaw development of the Kaiser system's first operating room for endovascular surgery (less invasive procedures to repair blood vessels).

Schneider has served as president of the Western Vascular Society and on many committees of the Society for Vascular Surgery. He is a fellow of the American College of Surgeons, distinguished fellow of the Society for Vascular Surgery and fellow of the International Society of Vascular Surgery. He has authored several textbooks, including the fourth edition of Endovascular Skills: Guidewire and Catheter Skills for Endovascular Surgery, as well as more than 100 articles in peer-reviewed journals. He founded two medical device companies, has served as an adviser to many others and holds numerous patents.

Education

Institution Degree Dept or School End Date
UCSF Fellowship Vascular Surgery 1991
UCSF Residency General Surgery 1989
Johns Hopkins University School of Medicine MD 1983

Board Certifications

American Board of Surgery, Vascular Surgery

Clinical Expertise

Abdominal Aortic Aneurysm
Carotid Artery Disease
Complex Limb Revascularization
Critical Limb Ischemia
Diabetic Vascular Disease
Dialysis Access
Endovascular Aneurysm Repair
Mesenteric Artery Disease
Peripheral Artery Disease
Thoracic Aortic Aneurysm
Thoracic Outlet Syndrome

In the News

BEST-CLI Landmark Trial Published in NEJM
November, 09, 2022 | UCSF Division of Vascular & Endovascular Surgery

Research Narrative

Dr. Schneider has served as National Principal Investigator for numerous clinical trials. Over 25 years, he has been a strong proponent of clinical research in vascular disease and has participated extensively in trial design, oversight, core lab analysis, events committees, data analysis, follow up, presentation, and publication. He has consulted on the regulatory pathway and pivotal trials for many vascular devices, has participated in numerous meetings with the FDA and has testified at FDA panel hearings. His experience includes performing procedures for several first-in-human trials. 

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 143
  1. Large language models can accurately populate Vascular Quality Initiative procedural databases using narrative operative reports.
    Flanagan CP, Trang K, Nacario J, Schneider PA, Gasper WJ, Conte MS, Wick EC, Conway AM| | PubMed
  2. Clinical and economic implications of focal dissection treatment following percutaneous transluminal angioplasty of the superficial femoral artery: an exploratory analysis based on the TOBA II Study.
    Pietzsch JB, Geisler BP, Garner AM, Ryschon AM, Gray WA, Fujihara M, Schneider PA| | PubMed
  3. Results of SurVeil Versus IN.PACT Admiral Paclitaxel Coated Balloons in Femoropopliteal Arteries: Outcomes of the Randomised TRANSCEND Study Through 24 Months.
    Brodmann M, Gray WA, Schneider PA, Kurzmann-Guetl K, Schweiger L, Zeller T, Thieme M, Kilaru S, Bachinsky WB, Feldman RL, Holden A, Varcoe RL, Lansky AJ, Rosenfield K, TRANSCEND Study Investigators| | PubMed
  4. An International, Expert-Based Delphi Consensus Document on Controversial Issues about TransCarotid Artery Revascularization (TCAR).
    Paraskevas KI, AbuRahma AF, Abularrage CJ, Clair DG, Eldrup-Jorgensen J, Kashyap VS, Dardik A, de Borst GJ, Dermody M, Faggioli G, Hicks CW, Kwolek CJ, Lyden SP, Mansilha A, Van Herzeele I, Myrcha P, Leal Lorenzo JI, Jim J, Pini R, Secemsky EA, Spinelli F, Capoccia L, Stone DH, Stoner MC, Zeebregts CJ, Lal BK, Schneider PA, Malas MB, Schermerhorn ML| | PubMed
  5. The impact of revascularization strategy on clinical failure, hemodynamic failure, and chronic limb-threatening ischemia symptoms in the BEST-CLI Trial.
    Menard MT, Farber A, Doros G, McGinigle KL, Chisci E, Clavijo LC, Kayssi A, Schneider PA, Hawkins BM, Dake MD, Hamza T, Strong MB, Rosenfield K, Conte MS| | PubMed
  6. Paclitaxel-Mortality Risk Hypothesis Debunked: What We Learned and How It Will Change Future Clinical Trials.
    Schneider PA, Olin JW| | PubMed
  7. The "Woundosome" Concept and Its Impact on Procedural Outcomes in Patients With Chronic Limb-Threatening Ischemia.
    Patrone L, Pasqui E, Conte MS, Farber A, Ferraresi R, Menard M, Mills JL, Rundback J, Schneider P, Ysa A, Abhishek K, Adams GL, Ahmad N, Ahmed I, Alexandrescu VA, Amor M, Alper D, Andrassy M, Attinger C, Baadh A, Barakat H, Biasi L, Bisdas T, Bhatti Z, Blessing E, Bonaca MP, Bonvini S, Bosiers M, Bradbury AW, Beasley R, Behrendt CA, Brodmann M, Cabral G, Cancellieri R, Casini A, Chandra V, Chisci E, Chohan O, Choke ETC, Chong PFS, Clerici G, Coscas R, Costantino M, Dalla Paola L, Dand S, Davies RSM, D'Oria M, Diamantopoulos A, Debus S, Deloose K, Del Giudice C, Donato G, Rubertis B, Paul De Vries J, Dias NV, Diaz-Sandoval L, Dick F, Donas K, Dua A, Fanelli F, Fazzini S, Foteh M, Gandini R, Gargiulo M, Garriboli L, Genovese EA, Gifford E, Goueffic Y, Goverde P, Chand Gupta P, Hinchliffe R, Holden A, Houlind KC, Howard DP, Huasen B, Isernia G, Katsanos K, Katzen B, Kolh P, Koncar I, Korosoglou G, Krishnan P, Kroencke T, Krokidis M, Kumarasamy A, Hayes P, Iida O, Alejandre Lafont E, Langhoff R, Lecis A, Lessne M, Lichaa H, Lichtenberg M, Lobato M, Lopes A, Loreni G, Lucatelli P, Madassery S, Maene L, Manzi M, Maresch M, Santhosh Mathews J, McCaslin J, Micari A, Michelagnoli S, Migliara B, Morgan R, Morelli L, Morosetti D, Mouawad N, Moxey P, Müller-Hülsbeck S, Mustapha J, Nakama T, Nasr B, N'dandu Z, Neville R, Noory E, Nordanstig J, Noronen K, Mariano Palena L, Parlani G, Patel AS, Patel P, Patel R, Patel S, Pena C, Perkov D, Portou M, Pratesi G, Rammos C, Reekers J, Riambau V, Roy T, Rosenfield K, Antonella Ruffino M, Saab F, Saratzis A, Sbarzaglia P, Schmidt A, Secemsky E, Siah M, Sillesen H, Simonte G, Sirvent M, Sommerset J, Steiner S, Sakr A, Scheinert D, Shishebor M, Spiliopoulos S, Spinelli A, Stravoulakis K, Taneva G, Teso D, Tessarek J, Theivacumar S, Thomas A, Thomas S, Thulasidasan N, Torsello G, Tripathi R, Troisi N, Tummala S, Tummala V, Twine C, Uberoi R, Ucci A, Valenti D, van den Berg J, van den Heuvel D, Van Herzeele I, Varcoe R, Vega de Ceniga M, Veith FJ, Venermo M, Vijaynagar B, Virdee S, Von Stempel C, Voûte MT, Khee Yeung K, Zeller T, Zayed H, Montero Baker M| | PubMed
  8. Why selective screening for asymptomatic carotid stenosis is currently appropriate: a special report.
    Paraskevas KI, Dardik A, Schermerhorn ML, Liapis CD, Mansilha A, Lal BK, Gray WA, Brown MM, Myrcha P, Lavie CJ, Zeebregts CJ, Secemsky EA, Saba L, Blecha M, Gurevich V, Silvestrini M, Blinc A, Svetlikov A, Fernandes E Fernandes J, Schneider PA, Gloviczki P, White CJ, AbuRahma AF| | PubMed
  9. Relevance of BEST-CLI trial endpoints in a tertiary care limb preservation program.
    Liu IH, El Khoury R, Hiramoto JS, Gasper WJ, Schneider PA, Vartanian SM, Conte MS| | PubMed
  10. The End of a Controversy: The Rise, Fall, and Redemption of Paclitaxel-Coated Devices.
    Secemsky EA, Yeh RW, Schneider PA, Gray W, Parikh S| | PubMed
  11. Serration Angioplasty Is Associated With Less Recoil in Infrapopliteal Arteries Compared With Plain Balloon Angioplasty.
    Fereydooni A, Chandra V, Schneider PA, Giasolli R, Lichtenberg M, Stahlhoff S| | PubMed
  12. Recent advances and controversial issues in the optimal management of asymptomatic carotid stenosis.
    Paraskevas KI, Brown MM, Lal BK, Myrcha P, Lyden SP, Schneider PA, Poredos P, Mikhailidis DP, Secemsky EA, Musialek P, Mansilha A, Parikh SA, Silvestrini M, Lavie CJ, Dardik A, Blecha M, Liapis CD, Zeebregts CJ, Nederkoorn PJ, Poredos P, Gurevich V, Jawien A, Lanza G, Gray WA, Gupta A, Svetlikov AV, Fernandes E Fernandes J, Nicolaides AN, White CJ, Meschia JF, Cronenwett JL, Schermerhorn ML, AbuRahma AF| | PubMed
  13. Outcomes following carotid revascularization for stroke stratified by Modified Rankin Scale and time of intervention.
    Solomon Y, Conroy PD, Rastogi V, Yadavalli SD, Schneider PA, Wang GJ, Malas MB, de Borst GJ, Schermerhorn ML| | PubMed
  14. Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures: an updated patient-level meta-analysis.
    Parikh SA, Schneider PA, Mullin CM, Rogers T, Gray WA| | PubMed
  15. The conundrum of below the knee (BTK) drug delivery.
    Schneider PA| | PubMed
  16. Female and male patients have similar outcomes after transcarotid artery revascularization in prospective trials.
    Smith JA, Chung JM, Schneider PA, Kwolek CJ, Arko FR, Henao S, Titus J, DiMuzio P, Roddy S, Farber MA, Kashyap VS, ROADSTER Trial Investigators| | PubMed
  17. Treatment effect of medial arterial calcification in below-knee after Auryon laser atherectomy using micro-CT and histologic evaluation.
    Rundback J, Kawai K, Sato Y, Brodmann M, Schneider P, Corbet MB, Kawakami R, Konishi T, Ghosh SKB, Virmani R, Finn AV| | PubMed
  18. Delphi Consensus on Reporting Standards in Clinical Studies for Endovascular Treatment of Acute Iliofemoral Venous Thrombosis and Chronic Iliofemoral Venous Obstruction.
    Vedantham S, Gloviczki P, Carman TL, Zelman Lewis S, Schneider PA, Sabri SS, Kolluri R| | PubMed
  19. How I do it: optimizing angioplasty using the Tack endovascular system in the management of chronic limb threatening ischemia.
    Siah MC, Babb J, Schneider PA| | PubMed
  20. Best Medical Treatment Alone Is Adequate for the Management of All Patients With Asymptomatic Carotid Stenosis, or "Alice in Wonderland".
    Paraskevas KI, Conrad MF, Schneider PA, Cambria RP| | PubMed
  21. High-Risk Characteristics for Clinical Failure after Isolated Femoropopliteal Peripheral Vascular Interventions.
    Kim TI, Schneider PA, Iannuzzi J, Ochoa Chaar CI| | PubMed
  22. Long-term outcomes of peripheral atherectomy for femoropopliteal endovascular interventions.
    Krawisz AK, Raja A, Jones WS, Schneider P, Shen C, Schermerhorn M, Secemsky EA| | PubMed
  23. Cognitive Impairment is Common in a Veterans Affairs Population with Peripheral Arterial Disease.
    Smith EJT, Gasper WJ, Schneider PA, Finlayson E, Walter LC, Covinsky KE, Conte MS, Iannuzzi JC| | PubMed
  24. Presenting limb severity is associated with long-term outcomes after infrainguinal revascularization for chronic limb-threatening ischemia.
    Liu IH, El Khoury R, Wu B, Gasper WJ, Schneider PA, Hiramoto JS, Vartanian SM, Conte MS| | PubMed
  25. Efficacy and safety of single versus dual antiplatelet therapy in carotid artery stenting.
    Marcaccio CL, Patel PB, Rastogi V, Stangenberg L, Liang P, Wyers MC, Jim J, Schneider PA, Schermerhorn ML| | PubMed
  26. Physiologic risk factors increase risk of myocardial infarction with transcarotid artery revascularization in prospective trials.
    Chung J, Kumins NH, Smith J, Motaganahalli RL, Schneider PA, Kwolek CJ, Kashyap VS, ROADSTER Investigators| | PubMed
  27. In-hospital outcomes after carotid endarterectomy for stroke stratified by modified Rankin scale score and time of intervention.
    Solomon Y, Marcaccio CL, Rastogi V, Lu JJ, Malas MB, Wang GJ, Schneider PA, de Borst GJ, Schermerhorn ML| | PubMed
  28. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.
    Farber A, Menard MT, Conte MS, Kaufman JA, Powell RJ, Choudhry NK, Hamza TH, Assmann SF, Creager MA, Cziraky MJ, Dake MD, Jaff MR, Reid D, Siami FS, Sopko G, White CJ, van Over M, Strong MB, Villarreal MF, McKean M, Azene E, Azarbal A, Barleben A, Chew DK, Clavijo LC, Douville Y, Findeiss L, Garg N, Gasper W, Giles KA, Goodney PP, Hawkins BM, Herman CR, Kalish JA, Koopmann MC, Laskowski IA, Mena-Hurtado C, Motaganahalli R, Rowe VL, Schanzer A, Schneider PA, Siracuse JJ, Venermo M, Rosenfield K, BEST-CLI Investigators| | PubMed
  29. Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients With Femoropopliteal Arterial Disease.
    Shishehbor MH, Scheinert D, Jain A, Brodmann M, Tepe G, Ando K, Krishnan P, Iida O, Laird JR, Schneider PA, Rocha-Singh KJ, Zeller T| | PubMed
  30. Determinants of Drug-Coated Balloon Failure in Patients Undergoing Femoropopliteal Arterial Intervention.
    Krishnan P, Farhan S, Schneider P, Kamran H, Iida O, Brodmann M, Micari A, Sachar R, Urasawa K, Scheinert D, Ando K, Tarricone A, Doros G, Tepe G, Yokoi H, Laird J, Zeller T| | PubMed
  31. Editor's Choice - European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Radiation Safety.
    Modarai B, Haulon S, Ainsbury E, Böckler D, Vano-Carruana E, Dawson J, Farber M, Van Herzeele I, Hertault A, van Herwaarden J, Patel A, Wanhainen A, Weiss S, Bastos Gonçalves F, Björck M, Chakfé N, de Borst GJ, Coscas R, Dias NV, Dick F, Hinchliffe RJ, Kakkos SK, Koncar IB, Kolh P, Lindholt JS, Trimarchi S, Tulamo R, Twine CP, Vermassen F, Bacher K, Brountzos E, Fanelli F, Fidalgo Domingos LA, Gargiulo M, Mani K, Mastracci TM, Maurel B, Morgan RA, Schneider P| | PubMed
  32. State-of-the-Art Endovascular Therapies for the Femoropopliteal Segment: Are We There Yet?
    Mosarla RC, Armstrong E, Bitton-Faiwiszewski Y, Schneider PA, Secemsky EA| | PubMed
  33. Pedal arterial calcification score is associated with hemodynamic change and major amputation after infrainguinal revascularization for chronic limb-threatening ischemia.
    Liu IH, Wu B, Krepkiy V, El Khoury R, Ferraresi R, Reyzelman AM, Hiramoto JS, Schneider PA, Conte MS, Vartanian SM| | PubMed
  34. Limb-based patency as a measure of effective revascularization for chronic limb-threatening ischemia.
    El Khoury R, Wu B, Kupiec-Weglinski SA, Liu IH, Edwards CT, Lancaster EM, Hiramoto JS, Vartanian SM, Schneider PA, Conte MS| | PubMed
  35. Concomitant Drug-Coated Balloon Angioplasty With Bail-Out Use of Eluvia Drug-Eluting Stent: Is There Any Downside to a Double Dose of Paclitaxel?
    Giannopoulos S, Secemsky EA, Schneider PA, Armstrong EJ| | PubMed
  36. One-year outcomes after transcarotid artery revascularization (TCAR) in the ROADSTER 2 trial.
    Kashyap VS, So KL, Schneider PA, Rathore R, Pham T, Motaganahalli RL, Massop DW, Foteh MI, Eckstein HH, Jim J, Leal Lorenzo JI, Melton JG| | PubMed
  37. Applicability of the Vascular Quality Initiative mortality prediction model for infrainguinal revascularization in a tertiary limb preservation center population.
    El Khoury R, Wu B, Kupiec-Weglinski SA, Dang LE, Edwards CT, Lancaster EM, Hiramoto JS, Vartanian SM, Schneider PA, Simons JP, Conte MS| | PubMed
  38. Balloon dilation strategy does not affect outcomes for transcarotid artery revascularization in prospective trials.
    Thomas JP, Kumins NH, Schneider PA, Kwolek CJ, Malas MB, Schermerhorn ML, Patel AJ, Motaganahalli RL, Stoner MC, Cambria RP, Kashyap VS| | PubMed
  39. Carotid Interventions for Women: The Hazards and Benefits.
    Rockman C, Caso V, Schneider PA| | PubMed
  40. It is time for a deep dive on our business model.
    Schneider PA| | PubMed
  41. Objective Outcome Measures for Trials in Patients With Chronic Limb-Threatening Ischemia Across 2 Decades: Analysis and Recommendations.
    Lakhter V, Weinberg MD, Galmer A, Mishra S, Dalsania R, Das S, Geraghty PJ, Jaff MR, Schneider PA, Weinberg I| | PubMed
  42. Delphi Consensus Study Toward a Comprehensive Classification System for Angioplasty-Induced Femoropopliteal Dissection: The DISFORM Study.
    Voûte MT, Stathis A, Schneider PA, Thomas SD, Brodmann M, Armstrong EJ, Holden A, Varcoe RL| | PubMed
  43. Endovascular treatment of high-risk peripheral vascular occlusive lesions: a review of current evidence and emerging applications of intravascular lithotripsy, atherectomy, and paclitaxel-coated devices.
    Sanders KM, Schneider PA, Conte MS, Iannuzzi JC| | PubMed
  44. Efficacy and safety of perioperative dual antiplatelet therapy with ticagrelor versus clopidogrel in carotid artery stenting.
    Marcaccio CL, Patel PB, Liang P, Rastogi V, Stangenberg L, Jim J, Schneider PA, Schermerhorn ML| | PubMed
  45. Progress on developing an effective below-the-knee drug-coated balloon.
    El Khoury R, Brodmann M, Schneider PA| | PubMed
  46. Pedal arterial calcification score is associated with the risk of major amputation in chronic limb-threatening ischemia.
    Liu IH, Wu B, Krepkiy V, Ferraresi R, Reyzelman AM, Hiramoto JS, Schneider PA, Conte MS, Vartanian SM| | PubMed
  47. Assessing the suitability of the carotid bifurcation for stenting: Anatomic and morphologic considerations.
    Kokkosis AA, Macdonald S, Jim J, Shah R, Schneider PA| | PubMed
  48. Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure.
    Vogler S, Schneider P, Zuba M, Busse R, Panteli D| | PubMed
  49. Advances in Revascularization for Peripheral Artery Disease: Revascularization in PAD.
    Beckman JA, Schneider PA, Conte MS| | PubMed
  50. Mortality Rates After Paclitaxel-Coated Device Use in Patients With Occlusive Femoropopliteal Disease: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Dinh K, Limmer AM, Chen AZL, Thomas SD, Holden A, Schneider PA, Varcoe RL| | PubMed
  51. Association of Postangioplasty Femoropopliteal Dissections With Outcomes After Drug-Coated Balloon Angioplasty in the Femoropopliteal Arteries.
    Giannopoulos S, Strobel A, Rudofker E, Kovach C, Schneider PA, Armstrong EJ| | PubMed
  52. PROMISE I: Early feasibility study of the LimFlow System for percutaneous deep vein arterialization in no-option chronic limb-threatening ischemia: 12-month results.
    Clair DG, Mustapha JA, Shishehbor MH, Schneider PA, Henao S, Bernardo NN, Deaton DH| | PubMed
  53. Understanding value and patient complexity among common inpatient vascular surgery procedures.
    Ramirez JL, Lopez J, Sanders K, Schneider PA, Gasper WJ, Conte MS, Sosa JA, Iannuzzi JC| | PubMed
  54. Closure device use for common femoral artery antegrade access is higher risk than retrograde access.
    Ramirez JL, Smith EJT, Zarkowsky DS, Lopez J, Hicks CW, Schneider PA, Conte MS, Iannuzzi JC| | PubMed
  55. The Global Limb Anatomic Staging System is associated with outcomes of infrainguinal revascularization in chronic limb threatening ischemia.
    El Khoury R, Wu B, Edwards CT, Lancaster EM, Hiramoto JS, Vartanian SM, Schneider PA, Conte MS| | PubMed
  56. Venous outcomes at 1 year after using the femoral vein as a conduit for passage of percutaneous femoropopliteal bypass.
    Schneider PA, Krievins DK, Halena G, Schmidt A, Lyden S, Lee V, Hu M, Adelman M| | PubMed
  57. Duplex Ultrasound Surveillance after Transcarotid Artery Revascularization (TCAR) in Clinical Practice.
    Beeman BR, Kuhn BA, Recht MH, Muck PE, Schneider PA| | PubMed
  58. Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulation.
    Vogler S, Schneider P, Lepuschütz L| | PubMed
  59. A Review and Proposed Classification System for the No-Option Patient With Chronic Limb-Threatening Ischemia.
    Kim TI, Vartanian SS, Schneider PA| | PubMed
  60. Effects of external crushing forces on a novel below-the-knee vascular implant.
    Longo M, Valentine H, Nikanorov A, Horzewski M, Teigen N, Schneider PA| | PubMed
  61. Update on paclitaxel for femoral-popliteal occlusive disease in the 15 months following a summary level meta-analysis demonstrated increased risk of late mortality and dose response to paclitaxel.
    Schneider PA, Varcoe RL, Secemsky E, Schermerhorn M, Holden A| | PubMed
  62. Paclitaxel exposure: Long-term safety and effectiveness of a drug-coated balloon for claudication in pooled randomized trials.
    Schneider PA, Brodmann M, Mauri L, Laird J, Soga Y, Micari A, Ansel G, Shishehbor MH, Krishnan P, Gao Q, Ouriel K, Zeller T| | PubMed
  63. Early Outcomes in the ROADSTER 2 Study of Transcarotid Artery Revascularization in Patients With Significant Carotid Artery Disease.
    Kashyap VS, Schneider PA, Foteh M, Motaganahalli R, Shah R, Eckstein HH, Henao S, LaMuraglia G, Stoner MC, Melton J, Massop D, Hanover T, Titus J, Moore WS, Rodríguez-Carvajal R, Malas MB, Arko FR, Pierce D, Anain P, Oskin T, ROADSTER 2 Investigators*| | PubMed
  64. Corrigendum to "Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischaemia" [Eur J Vasc Endovasc Surg 58 (1S) (2019) 1-109>].
    Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH, Aboyans V, Aksoy M, Alexandrescu VA, Armstrong D, Azuma N, Belch J, Bergoeing M, Bjorck M, Chakfé N, Cheng S, Dawson J, Debus ES, Dueck A, Duval S, Eckstein HH, Ferraresi R, Gambhir R, Gargiulo M, Geraghty P, Goode S, Gray B, Guo W, Gupta PC, Hinchliffe R, Jetty P, Komori K, Lavery L, Liang W, Lookstein R, Menard M, Misra S, Miyata T, Moneta G, Munoa Prado JA, Munoz A, Paolini JE, Patel M, Pomposelli F, Powell R, Robless P, Rogers L, Schanzer A, Schneider P, Taylor S, De Ceniga MV, Veller M, Vermassen F, Wang J, Wang S, GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS), European Society for Vascular Surgery (ESVS), World Federation of Vascular Societies (WFVS)| | PubMed
  65. Total IN.PACT All-Subjects One-Year Analysis and Standard vs Broader Implications.
    Kobe DS, Jaff MR, Zeller T, Schneider PA, Shishehbor MH| | PubMed
  66. Balloon Angioplasty of Infrapopliteal Arteries: A Systematic Review and Proposed Algorithm for Optimal Endovascular Therapy.
    Giannopoulos S, Varcoe RL, Lichtenberg M, Rundback J, Brodmann M, Zeller T, Schneider PA, Armstrong EJ| | PubMed
  67. Endovascular Intervention for the Treatment of Trans-Atlantic Inter-Society Consensus (TASC) D Femoropopliteal Lesions: A Systematic Review and Meta-Analysis.
    Giannopoulos S, Lyden SP, Bisdas T, Micari A, Parikh SA, Jaff MR, Schneider PA, Armstrong EJ| | PubMed
  68. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
    Giannopoulos S, Ghanian S, Parikh SA, Secemsky EA, Schneider PA, Armstrong EJ| | PubMed
  69. New Innovations and Devices in the Management of Chronic Limb-Threatening Ischemia.
    Kim TI, Schneider PA| | PubMed
  70. Mortality and Paclitaxel-Coated Devices: An Individual Patient Data Meta-Analysis.
    Rocha-Singh KJ, Duval S, Jaff MR, Schneider PA, Ansel GM, Lyden SP, Mullin CM, Ioannidis JPA, Misra S, Tzafriri AR, Edelman ER, Granada JF, White CJ, Beckman JA, VIVA Physicians, Inc| | PubMed
  71. Re: Risk of Death and Amputation with Use of Paclitaxel-Coated Balloons in the Infrapopliteal Arteries for Treatment of Critical Limb Ischemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Schneider PA, Varcoe RL| | PubMed
  72. Mortality After Paclitaxel-Coated Device Use in Patients With Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Dinh K, Gomes ML, Thomas SD, Paravastu SCV, Holden A, Schneider PA, Varcoe RL| | PubMed
  73. Corrigendum to 'Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia' [European Journal of Vascular & Endovascular Surgery 58/1S (2019) 1-109].
    Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH, Aboyans V, Aksoy M, Alexandrescu VA, Armstrong D, Azuma N, Belch J, Bergoeing M, Bjorck M, Chakfé N, Cheng S, Dawson J, Debus ES, Dueck A, Duval S, Eckstein HH, Ferraresi R, Gambhir R, Garguilo M, Geraghty P, Goode S, Gray B, Guo W, Gupta PC, Hinchliffe R, Jetty P, Komori K, Lavery L, Liang W, Lookstein R, Menard M, Misra S, Miyata T, Moneta G, Munoa Prado JA, Munoz A, Paolini JE, Patel M, Pomposelli F, Powell R, Robless P, Rogers L, Schanzer A, Schneider P, Taylor S, Vega de Ceniga M, Veller M, Vermassen F, Wang J, Wang S, GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS), European Society for Vascular Surgery (ESVS), and World Federation of Vascular Societies (WFVS)| | PubMed
  74. Evaluation of a novel mesh-covered stent for treatment of carotid stenosis in patients at high risk for endarterectomy: 1-year results of the SCAFFOLD trial.
    Gray WA, Levy E, Bacharach JM, Metzger DC, Randall B, Siddiqui A, Schonholz C, Alani F, Schneider PA| | PubMed
  75. Total IN.PACT drug-coated balloon initiative reporting pooled imaging and propensity-matched cohorts.
    Shishehbor MH, Schneider PA, Zeller T, Razavi MK, Laird JR, Wang H, Tieché C, Parikh SA, Iida O, Jaff MR| | PubMed
  76. Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing.
    Vogler S, Schneider P, Zimmermann N| | PubMed
  77. Dissections After Infrainguinal Percutaneous Transluminal Angioplasty: A Systematic Review and Current State of Clinical Evidence.
    Armstrong EJ, Brodmann M, Deaton DH, Gray WA, Jaff MR, Lichtenberg M, Rundback JH, Schneider PA| | PubMed
  78. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions.
    Laird JA, Schneider PA, Jaff MR, Brodmann M, Zeller T, Metzger DC, Krishnan P, Scheinert D, Micari A, Wang H, Masters M, Tepe G| | PubMed
  79. Affordable and equitable access to subsidised outpatient medicines? Analysis of co-payments under the Additional Drug Package in Kyrgyzstan.
    Vogler S, Schneider P, Dedet G, Bak Pedersen H| | PubMed
  80. Disparities in Contemporary Treatment Rates of Abdominal Aortic Aneurysms Across Western Countries.
    Castro-Ferreira R, Lachat M, Schneider PA, Freitas A, Leite-Moreira A, Sampaio SM| | PubMed
  81. Paclitaxel and Mortality: The Dose Argument Is Critical.
    Holden A, Varcoe RL, Jaff MR, Schneider PA, Tepe G, Zeller T| | PubMed
  82. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.
    Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH, Aboyans V, Aksoy M, Alexandrescu VA, Armstrong D, Azuma N, Belch J, Bergoeing M, Bjorck M, Chakfé N, Cheng S, Dawson J, Debus ES, Dueck A, Duval S, Eckstein HH, Ferraresi R, Gambhir R, Gargiulo M, Geraghty P, Goode S, Gray B, Guo W, Gupta PC, Hinchliffe R, Jetty P, Komori K, Lavery L, Liang W, Lookstein R, Menard M, Misra S, Miyata T, Moneta G, Munoa Prado JA, Munoz A, Paolini JE, Patel M, Pomposelli F, Powell R, Robless P, Rogers L, Schanzer A, Schneider P, Taylor S, De Ceniga MV, Veller M, Vermassen F, Wang J, Wang S, GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS), European Socie| | PubMed
  83. Interim Results of the PROMISE I Trial to Investigate the LimFlow System of Percutaneous Deep Vein Arterialization for the Treatment of Critical Limb Ischemia.
    Mustapha JA, Saab FA, Clair D, Schneider P| | PubMed
  84. Continuous monitoring of interstitial tissue oxygen using subcutaneous oxygen microsensors: In vivo characterization in healthy volunteers.
    Kanick SC, Schneider PA, Klitzman B, Wisniewski NA, Rebrin K| | PubMed
  85. Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon.
    Schneider PA, Laird JR, Doros G, Gao Q, Ansel G, Brodmann M, Micari A, Shishehbor MH, Tepe G, Zeller T| | PubMed
  86. A First-in-Human Evaluation of a Novel Mesh-Covered Stent for Treatment of Carotid Stenosis in Patients at High Risk for Endarterectomy: 30-Day Results of the SCAFFOLD Trial.
    Schneider PA, Levy E, Bacharach JM, Metzger DC, Randall B, Garcia A, Siddiqui A, Schonholz C, Gray W| | PubMed
  87. Centers for Medicare & Medicaid Services' decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence.
    Shishehbor MH, White CJ, Beckman JA, Misra S, Schneider PA, Lookstein RA, Kashyap VS, Clair D, Jones WS, Rosenfield K, Katzen BT, Jaff MR| | PubMed
  88. Response by Schneider et al to Letter Regarding Article, "Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial".
    Schneider PA, Laird JR, Tepe G, Brodmann M, Zeller T, Scheinert D, Metzger C, Micari A, Sachar R, Jaff MR, Wang H, Hasenbank MS, Krishnan P, IN.PACT SFA Trial Investigators| | PubMed
  89. Treatment of infrapopliteal post-PTA dissection with tack implants: 12-month results from the TOBA-BTK study.
    Brodmann M, Wissgott C, Holden A, Staffa R, Zeller T, Vasudevan T, Schneider P| | PubMed
  90. Public Health Impact of the Centers for Medicare and Medicaid Services Decision on Pass-Through Add-On Payments for Drug-Coated Balloons: A Call to Action.
    Shishehbor MH, Jaff MR, Beckman JA, Misra S, Schneider PA, Lookstein R, Kashyap VS, Aronow HD, Jones WS, White CJ| | PubMed
  91. Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial.
    Schneider PA, Laird JR, Tepe G, Brodmann M, Zeller T, Scheinert D, Metzger C, Micari A, Sachar R, Jaff MR, Wang H, Hasenbank MS, Krishnan P, IN.PACT SFA Trial Investigators| | PubMed
  92. Novel Nitinol Stent for Lesions up to 24 cm in the Superficial Femoral and Proximal Popliteal Arteries: 24-Month Results From the TIGRIS Randomized Trial.
    Laird JR, Zeller T, Loewe C, Chamberlin J, Begg R, Schneider PA, Nanjundappa A, Bunch F, Schultz S, Harlin S, Lansky A, Jaff MR| | PubMed
  93. Evolution and current use of technology for superficial femoral and popliteal artery interventions for claudication.
    Schneider PA| | PubMed
  94. Carotid artery stenting should remain an alternative to endarterectomy in selected patients.
    Schneider PA| | PubMed
  95. How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries.
    Vogler S, Paris V, Ferrario A, Wirtz VJ, de Joncheere K, Schneider P, Pedersen HB, Dedet G, Babar ZU| | PubMed
  96. Will mesh-covered stents help reduce stroke associated with carotid stent angioplasty?
    Richards CN, Schneider PA| | PubMed
  97. Prevalence and function of Heschl's gyrus morphotypes in musicians.
    Benner J, Wengenroth M, Reinhardt J, Stippich C, Schneider P, Blatow M| | PubMed
  98. Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
    Rocha-Singh KJ, Beckman JA, Ansel G, Lyden SP, Schneider P, Mehta M, Dake M, Mullin CM, Jaff MR, VIVA Physicians, Inc| | PubMed
  99. Western Vascular Society guidelines for transfer of patients with ruptured abdominal aortic aneurysm.
    Mell MW, Starnes BW, Kraiss LW, Schneider PA, Pevec WC| | PubMed
  100. Cost-Effectiveness of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons Versus Standard Percutaneous Transluminal Angioplasty: Results From the IN.PACT SFA II Trial.
    Salisbury AC, Li H, Vilain KR, Jaff MR, Schneider PA, Laird JR, Cohen DJ| | PubMed
  101. Prescription of Guideline-Based Medical Therapies at Discharge After Carotid Artery Stenting and Endarterectomy: An NCDR Analysis.
    Aronow HD, Kennedy KF, Wayangankar SA, Katzen BT, Schneider PA, Abou-Chebl A, Rosenfield KA| | PubMed
  102. Neural Biomarkers for Dyslexia, ADHD, and ADD in the Auditory Cortex of Children.
    Serrallach B, Groß C, Bernhofs V, Engelmann D, Benner J, Gündert N, Blatow M, Wengenroth M, Seitz A, Brunner M, Seither S, Parncutt R, Schneider P, Seither-Preisler A| | PubMed
  103. Comparative Effectiveness of Carotid Artery Stenting Versus Carotid Endarterectomy Among Medicare Beneficiaries.
    Jalbert JJ, Nguyen LL, Gerhard-Herman MD, Kumamaru H, Chen CY, Williams LA, Liu J, Rothman AT, Jaff MR, Seeger JD, Benenati JF, Schneider PA, Aronow HD, Johnston JA, Brott TG, Tsai TT, White CJ, Setoguchi S| | PubMed
  104. Bare metal stenting of the iliac arteries.
    Kim TI, Schneider PA| | PubMed
  105. Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA.
    Laird JR, Schneider PA, Tepe G, Brodmann M, Zeller T, Metzger C, Krishnan P, Scheinert D, Micari A, Cohen DJ, Wang H, Hasenbank MS, Jaff MR, IN.PACT SFA Trial Investigators| | PubMed
  106. Relationship Between Physician and Hospital Procedure Volume and Mortality After Carotid Artery Stenting Among Medicare Beneficiaries.
    Jalbert JJ, Gerhard-Herman MD, Nguyen LL, Jaff MR, Kumamaru H, Williams LA, Chen CY, Liu J, Seeger JD, Rothman AT, Schneider P, Brott TG, Tsai TT, Aronow HD, Johnston JA, Setoguchi S| | PubMed
  107. Letter to the Editor Regarding the Article "Thyrotropin Suppression Increases the Risk of Osteoporosis Without Decreasing Recurrence in ATA Low- and Intermediate-Risk Patients with Differentiated Thyroid Carcinoma".
    Schneider P, Schneider R, Schneider M, Reiners C| | PubMed
  108. Drug-coated balloon treatment for lower extremity vascular disease intervention: an international positioning document.
    Cortese B, Granada JF, Scheller B, Schneider PA, Tepe G, Scheinert D, Garcia L, Stabile E, Alfonso F, Ansel G, Zeller T| | PubMed
  109. The future of vascular surgery.
    Schneider PA| | PubMed
  110. Variability in transfer criteria for patients with ruptured abdominal aortic aneurysm in the western United States.
    Mell MW, Schneider PA, Starnes BW| | PubMed
  111. Early experimental and clinical experience with a focal implant for lower extremity post-angioplasty dissection.
    Schneider PA, Giasolli R, Ebner A, Virmani R, Granada JF| | PubMed
  112. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.
    Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, Metzger C, Scheinert D, Zeller T, Cohen DJ, Snead DB, Alexander B, Landini M, Jaff MR, IN.PACT SFA Trial Investigators| | PubMed
  113. Stroke and the law: principles and practice.
    Fisher M, Schneider P| | PubMed
  114. Three-phase bone scintigraphy for imaging osteoradionecrosis of the jaw.
    Lapa C, Linz C, Bluemel C, Mottok A, Mueller-Richter U, Kuebler A, Schneider P, Czernin J, Buck AK, Herrmann K| | PubMed
  115. An evidence-based review of the impact of periprocedural myocardial infarction in carotid revascularization.
    Stilp E, Baird C, Gray WA, Schneider PA, Simonton CA, Verta P, Mena-Hurtado CI| | PubMed
  116. Re-entry into the true lumen from the subintimal space.
    Schneider PA, Caps MT, Nelken N| | PubMed
  117. Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: the XCELL trial.
    Rocha-Singh KJ, Jaff M, Joye J, Laird J, Ansel G, Schneider P, VIVA Physicians| | PubMed
  118. Endovascular therapy: is it effective in the diabetic limb?
    Pedrajas FG, Cafasso DE, Schneider PA| | PubMed
  119. Should Medicare reimbursement for carotid artery stenting be extended to standard and low risk symptomatic and asymptomatic patients with carotid stenosis?
    Gray WA, Macdonald S, Schneider PA| | PubMed
  120. Reporting standards for carotid interventions from the Society for Vascular Surgery.
    Timaran CH, McKinsey JF, Schneider PA, Littooy F| | PubMed
  121. Management of simultaneous common and internal carotid artery occlusive disease in the endovascular era.
    Moore JD, Schneider PA| | PubMed
  122. Asymptomatic carotid artery stenosis--medical therapy alone versus medical therapy plus carotid endarterectomy or stenting.
    Schneider PA, Naylor AR| | PubMed
  123. Infrainguinal vein graft stenosis: cutting balloon angioplasty as the first-line treatment of choice.
    Schneider PA, Caps MT, Nelken N| | PubMed
  124. Difficult anatomy: what characteristics are critical to good outcomes of either CEA or CAS?
    Schneider PA, Kasirajan K| | PubMed
  125. Transient sirolimus serum levels after implantation of a sirolimus eluting stent in an infant.
    Riede FT, Schneider P, Dähnert I| | PubMed
  126. Early post-convulsive prolongation of QT time in children.
    Kändler L, Fiedler A, Scheer K, Wild F, Frick U, Schneider P| | PubMed
  127. Carotid stenting.
    Schneider PA| | PubMed
  128. Establishing sheath access for carotid interventions: tips and pitfalls.
    Nelken N, Caps MT, Schneider PA| | PubMed
  129. Optimal training strategies for carotid stenting.
    Schneider PA| | PubMed
  130. What are the key factors in setting up a successful carotid stent program?
    Schneider PA, Silva MB| | PubMed
  131. What are the skills that prepare vascular surgeons for carotid stenting?
    Angle N, Schneider PA| | PubMed
  132. The route of administration (oral vs intravenous) does not influence dose or outcome in Graves' disease and unifocal autonomy.
    Schneider P, Biko J, Hänscheid H, Hilliger S, Koutsampelas C, Kranzfelder M, Ladner S, Reiners C| | PubMed
  133. Safety and efficacy of carotid arteriography in vascular surgery practice.
    Schneider PA, Silva MB, Bohannon WT, Kasirajan K, Caps MT, Nelken N, Santana D| | PubMed
  134. Advances in stent technology and drug-eluting stents.
    Nelken N, Schneider PA| | PubMed
  135. Effect of ethnicity on access and device complications during endovascular aneurysm repair.
    Masuda EM, Caps MT, Singh N, Yorita K, Schneider PA, Sato DT, Eklof B, Nelken NA, Kistner RL| | PubMed
  136. Early outcome of "cutting" balloon angioplasty for infrainguinal vein graft stenosis.
    Kasirajan K, Schneider PA| | PubMed
  137. Hiring practices ... not so fast!
    Schneider PA| | PubMed
  138. Autologous stem cell transplantation for systemic lupus erythematosus.
    Jayne D, Passweg J, Marmont A, Farge D, Zhao X, Arnold R, Hiepe F, Lisukov I, Musso M, Ou-Yang J, Marsh J, Wulffraat N, Besalduch J, Bingham SJ, Emery P, Brune M, Fassas A, Faulkner L, Ferster A, Fiehn C, Fouillard L, Geromin A, Greinix H, Rabusin M, Saccardi R, Schneider P, Zintl F, Gratwohl A, Tyndall A, European Group for Blood and Marrow Transplantation, European League Against Rheumatism Registry| | PubMed
  139. Filter devices for cerebral protection during carotid angioplasty and stenting.
    Kasirajan K, Schneider PA, Kent KC| | PubMed
  140. Iliac angioplasty and stenting in association with infrainguinal bypasses: timing and techniques.
    Schneider PA| | PubMed
  141. Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning.
    Kobbe G, Schneider P, Aivado M, Zohren F, Schubert D, Fenk R, Neumann F, Kronenwett R, Pape H, Rong A, Royer-Pokora B, Hildebrandt B, Germing U, Gattermann N, Heyll A, Haas R| | PubMed
  142. Endovascular or open surgery for aortoiliac occlusive disease?
    Schneider PA| | PubMed
  143. Soluble endothelial adhesion molecules during paediatric cardiovascular surgery with or without cardiopulmonary bypass.
    Osmancik P, Hambsch J, Schneider P, Bellinghausen W, Tarnok A| | PubMed